<DOC>
	<DOCNO>NCT02916394</DOCNO>
	<brief_summary>The investigator develop [ 68Ga ] -labelling Anti-IGF-1R Affibody Molecule target molecular imaging agent noninvasive repeatable detect IGF-1R expression status .</brief_summary>
	<brief_title>In Vivo IGF-1R Molecular Imaging Using 68Ga- Labelling Anti-IGF-1R Affibody Molecule</brief_title>
	<detailed_description>The goal investigator evaluate use [ 68Ga ] -labelling Anti-IGF-1R Affibody Molecule novel PET/CT radiotracer monitor IGF-1R expression status . The investigator want evaluate use [ 68Ga ] -labelling Anti-IGF-1R Affibody Molecule IGF-1R expression cancer image adult cancer patient （colon cancer 、NSCLC、gliomas cancer patients）with different IGF-1R expression status .</detailed_description>
	<criteria>1 . Colon cancer , NSCLC glioma patient pathological gene detection result receive treatment 2 . More 18 year old 3 . A life expectancy least 12 week 4 . Presence malignant lesion within chest least 0.5 cm diameter measure compute tomography ( CT ) 5 . Written inform consent 1 . Could get pathological gene detection result 2 . Pregnancy 3. want write inform consent。</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>